Biocon Ltd

NSE: BIOCON · BSE: 532523 · Pharmaceuticals & Biotechnology · 10 announcements

Share price: ₹382.15
Market cap: ₹62,279 Cr
Revenue (annual): ₹16,927 Cr
Net profit (annual): ₹385.6 Cr
P/E (TTM): 125.7×Sector 50.4×
Promoter holding: 44.68%-0.23% QoQ
FII holding: 8.14%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 2 New Order Win 1 Financial Results 1 Business Update 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

8 Sep 2026 08:31 IST NSE

New Order Win

Biocon Bags New Order from Bahiafarma and Bionovis

Biocon secured a 10-year supply contract for Pertuzumab in Brazil under a government program. The partnership involves milestone payments and revenue sharing for the company.

From: Bahiafarma and Bionovis (Brazil PDP program)
Execution: 10 years

Read the filing ↗